Exosome Diagnostics, Inc., a leader in the field of liquid biopsy, is headquartered in the United States and operates across key regions globally. Founded in 2013, the company has made significant strides in the diagnostics industry, focusing on the development of innovative exosome-based technologies for cancer detection and monitoring. Exosome Diagnostics offers a range of unique products and services, including its proprietary exosome isolation and analysis platforms, which enable non-invasive testing with high sensitivity and specificity. The company has established a strong market position, recognised for its contributions to precision medicine and biomarker discovery. With a commitment to advancing diagnostic capabilities, Exosome Diagnostics continues to set benchmarks in the evolving landscape of molecular diagnostics.
We don't have data for Exosome Diagnostics, Inc., but we can show you information about their parent organization instead.
View parent company